| P50 | author | Mauro V. Mendlowicz | Q104832000 |
| | Leonardo F. Fontenelle | Q37839644 |
| P2093 | author name string | Charles R Marmar | |
| | William Berger | |
| | Ivan Figueira | |
| | Carla Marques-Portella | |
| | Gustavo Kinrys | |
| P2860 | cites work | Prospective open-label study of add-on and monotherapy topiramate in civilians with chronic nonhallucinatory posttraumatic stress disorder | Q21260296 |
| | Pharmacotherapy for post traumatic stress disorder (PTSD) | Q24244802 |
| | A rating scale for depression | Q24564540 |
| | Chronic Sleep Disruption and the Reexperiencing Cluster of Posttraumatic Stress Disorder Symptoms Are Improved by Olanzapine: Brief Review of the Literature and a Case-Based Series | Q24596917 |
| | Successfully treating aggression in mentally ill prison inmates. | Q51973206 |
| | Low dose lithium carbonate in the treatment of post traumatic stress disorder: brief communication. | Q53856396 |
| | Short-term treatment of post-traumatic stress disorder with naltrexone: an open-label preliminary study | Q56681094 |
| | Risperidone in the treatment of acute stress disorder in physically traumatized in‐patients | Q56910344 |
| | Comorbidity, Impairment, and Suicidality in Subthreshold PTSD | Q60447049 |
| | Assessing impairment in patients with panic disorder: the Sheehan Disability Scale | Q68138375 |
| | Core symptoms of posttraumatic stress disorder unimproved by alprazolam treatment | Q68514426 |
| | Preliminary study of carbamazepine in post-traumatic stress disorder | Q68931051 |
| | Lithium in the treatment of aggression in mentally handicapped patients. A double-blind trial | Q70358490 |
| | Factors associated with a good response to lithium in aggressive mentally handicapped subjects | Q70517580 |
| | Vigabatrin and posttraumatic stress disorder | Q71216994 |
| | Clonidine for posttraumatic stress disorder in preschool children | Q71573724 |
| | Carbamazepine for PTSD | Q71868702 |
| | Fluoxetine in posttraumatic stress disorder | Q72391733 |
| | Fluoxetine in post-traumatic stress disorder. Randomised, double-blind study | Q73326033 |
| | Positive symptoms of psychosis in posttraumatic stress disorder | Q73390451 |
| | Dehydroepiandrosterone sulfate (DHEAS) counteracts decremental effects of corticosterone on dentate gyrus LTP. Implications for depression | Q73816116 |
| | Fluvoxamine in civilians with posttraumatic stress disorder | Q74212255 |
| | Further psychometric assessment of the TOP-8: a brief interview-based measure of PTSD | Q77836964 |
| | Divalproex in posttraumatic stress disorder: an open-label clinical trial | Q77909043 |
| | Randomized, double-blind pilot trial comparing lamotrigine versus citalopram for the treatment of bipolar depression | Q79838130 |
| | Efficacy and safety of topiramate monotherapy in civilian posttraumatic stress disorder: a randomized, double-blind, placebo-controlled study | Q79865951 |
| | Divalproex sodium for the treatment of PTSD and conduct disordered youth: a pilot randomized controlled clinical trial | Q80480436 |
| | 3-acetyl-7-oxo-dehydroepiandrosterone for healing treatment-resistant posttraumatic stress disorder in women: 5 case reports | Q83225428 |
| | The alpha1-adrenergic antagonist prazosin ameliorates combat trauma nightmares in veterans with posttraumatic stress disorder: a report of 4 cases. | Q45334638 |
| | A preliminary trial of nalmefene for the treatment of emotional numbing in combat veterans with post-traumatic stress disorder. | Q45336231 |
| | A preliminary case series on the use of quetiapine for posttraumatic stress disorder in juveniles within a youth detention center | Q46800075 |
| | Daytime prazosin reduces psychological distress to trauma specific cues in civilian trauma posttraumatic stress disorder | Q46929900 |
| | Kindling in the hypothalamus and transfer to the ipsilateral amygdala | Q48437493 |
| | Valproate in combat-related posttraumatic stress disorder | Q48660781 |
| | Cyproheptadine treatment of nightmares associated with posttraumatic stress disorder | Q48742433 |
| | Treatment of recent trauma survivors with benzodiazepines: a prospective study. | Q50865630 |
| | Lithium for irritability in post-traumatic stress disorder. | Q51128657 |
| | Risperidone monotherapy for post-traumatic stress disorder related to sexual assault and domestic abuse in women. | Q51914175 |
| | Levetiracetam for treatment-refractory posttraumatic stress disorder. | Q51919873 |
| | Adjunctive olanzapine for SSRI-resistant combat-related PTSD: a double-blind, placebo-controlled study | Q28204975 |
| | Amygdala, medial prefrontal cortex, and hippocampal function in PTSD | Q28256150 |
| | No improvement of posttraumatic stress disorder symptoms with guanfacine treatment | Q28277586 |
| | The positive and negative syndrome scale (PANSS) for schizophrenia | Q28301751 |
| | Efficacy and safety of sertraline treatment of posttraumatic stress disorder: a randomized controlled trial | Q28377040 |
| | The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research | Q29547257 |
| | Posttraumatic stress disorder in the National Comorbidity Survey | Q29616312 |
| | Prazosin effects on objective sleep measures and clinical symptoms in civilian trauma posttraumatic stress disorder: a placebo-controlled study | Q30481797 |
| | Glucocorticoids and hippocampal atrophy in neuropsychiatric disorders | Q31811786 |
| | A preliminary study of lamotrigine for the treatment of posttraumatic stress disorder | Q33862414 |
| | The psychobiology of posttraumatic stress disorder | Q33889843 |
| | Efficacy and safety of paroxetine treatment for chronic PTSD: a fixed-dose, placebo-controlled study | Q33956204 |
| | Open-label topiramate as primary or adjunctive therapy in chronic civilian posttraumatic stress disorder: a preliminary report. | Q33957343 |
| | Propranolol treatment for childhood posttraumatic stress disorder, acute type. A pilot study. | Q34168752 |
| | Reduction of nightmares and other PTSD symptoms in combat veterans by prazosin: a placebo-controlled study | Q34174352 |
| | Use of benzodiazepines in social anxiety disorder, generalized anxiety disorder, and posttraumatic stress disorder | Q34312612 |
| | Anti-glucocorticoid effects of dehydroepiandrosterone (DHEA). | Q34330536 |
| | Practice guideline for the treatment of patients with acute stress disorder and posttraumatic stress disorder | Q34379429 |
| | Efficacy of sertraline in preventing relapse of posttraumatic stress disorder: results of a 28-week double-blind, placebo-controlled study | Q34519704 |
| | Double-blind placebo-controlled pilot study of sertraline in military veterans with posttraumatic stress disorder | Q34521899 |
| | Olanzapine in the treatment-resistant, combat-related PTSD--a series of case reports. | Q34533757 |
| | Noradrenergic signaling in the amygdala contributes to the reconsolidation of fear memory: treatment implications for PTSD. | Q34554737 |
| | The role of anticonvulsant drugs in anxiety disorders: a critical review of the evidence | Q34628339 |
| | Prazosin reduces nightmares in combat veterans with posttraumatic stress disorder. | Q34764362 |
| | Antiepileptic drugs in posttraumatic stress disorder | Q34769378 |
| | Psychopharmacological treatment in PTSD: a critical review | Q34977242 |
| | The role of glutamate and gamma-aminobutyric acid in fear extinction: clinical implications for exposure therapy | Q35001310 |
| | SSRIs versus non-SSRIs in post-traumatic stress disorder: an update with recommendations | Q35669835 |
| | Current concepts in pharmacotherapy for posttraumatic stress disorder | Q35765268 |
| | Treatment-resistant posttraumatic stress disorder: strategies for intervention | Q35901891 |
| | Lamotrigine in psychiatry: pharmacology and therapeutics. | Q36060416 |
| | Case reports and case series from Lancet had significant impact on medical literature | Q36314363 |
| | Augmentation strategies for treatment-resistant depression: a literature review | Q36944073 |
| | Anxiety disorders: a comprehensive review of pharmacotherapies | Q37244064 |
| | An open-label pilot study of divalproex sodium for posttraumatic stress disorder related to childhood abuse | Q37721742 |
| | Divalproex for the treatment of posttraumatic stress disorder: a retrospective chart review | Q38220375 |
| | Placebo-controlled trial of risperidone augmentation for selective serotonin reuptake inhibitor-resistant civilian posttraumatic stress disorder. | Q38392129 |
| | Assessment of a new self-rating scale for post-traumatic stress disorder | Q39114859 |
| | SPRINT: a brief global assessment of post-traumatic stress disorder | Q39264309 |
| | Tiagabine for posttraumatic stress disorder: effects of open-label and double-blind discontinuation treatment | Q39269522 |
| | Treatment of posttraumatic stress disorder with venlafaxine extended release: a 6-month randomized controlled trial | Q39271019 |
| | The efficacy and tolerability of tiagabine in adult patients with post-traumatic stress disorder | Q39271632 |
| | Quetiapine as an adjunctive treatment for post-traumatic stress disorder: an 8-week open-label study | Q39358612 |
| | Preclinical pharmacology of neuroleptics: focus on new generation compounds. | Q41240744 |
| | Endogenous opioids, stress induced analgesia, and posttraumatic stress disorder | Q41288765 |
| | Prazosin reduces trauma-related nightmares in older men with chronic posttraumatic stress disorder | Q42608202 |
| | Olanzapine versus fluphenazine in an open trial in patients with psychotic combat-related post-traumatic stress disorder | Q42624134 |
| | A randomized, double-blind, placebo-controlled trial of augmentation topiramate for chronic combat-related posttraumatic stress disorder | Q42637059 |
| | Treatment of posttraumatic stress disorder with phenytoin: an open-label pilot study. | Q42641034 |
| | Quetiapine improves sleep disturbances in combat veterans with PTSD: sleep data from a prospective, open-label study | Q42662214 |
| | Risperidone in psychotic combat-related posttraumatic stress disorder: an open trial. | Q42662270 |
| | Adjunctive risperidone treatment and sleep symptoms in combat veterans with chronic PTSD. | Q42691667 |
| | Adjunctive risperidone in the treatment of chronic combat-related posttraumatic stress disorder | Q43529074 |
| | Olanzapine in the treatment of post-traumatic stress disorder: a pilot study | Q43679590 |
| | Fluvoxamine and sleep disturbances in posttraumatic stress disorder | Q43727338 |
| | Olanzapine treatment for post-traumatic stress disorder: an open-label study | Q43801930 |
| | Paroxetine in the treatment of chronic posttraumatic stress disorder: results of a placebo-controlled, flexible-dosage trial | Q43844465 |
| | Gabapentin in PTSD: a retrospective, clinical series of adjunctive therapy | Q43855060 |
| | The alpha1-adrenergic antagonist prazosin improves sleep and nightmares in civilian trauma posttraumatic stress disorder | Q43859442 |
| | Valproate therapy for chronic, combat-induced posttraumatic stress disorder | Q43859460 |
| | Adjunctive risperidone treatment in post-traumatic stress disorder: a preliminary controlled trial of effects on comorbid psychotic symptoms | Q44255097 |
| | The PTSD interview: rationale, description, reliability, and concurrent validity of a DSM-III-based technique | Q44269830 |
| | Hypnotic medication in the aftermath of trauma | Q44279857 |
| | Quetiapine treatment in patients with posttraumatic stress disorder: an open trial of adjunctive therapy | Q44289028 |
| | Low-dose risperidone as adjunctive therapy for irritable aggression in posttraumatic stress disorder | Q44364171 |
| | Quetiapine reduces flashbacks in chronic posttraumatic stress disorder | Q44459626 |
| | Valproate monotherapy in the treatment of civilian patients with non-combat-related posttraumatic stress disorder: an open-label study | Q44717928 |
| | An increased capacity for adrenal DHEA release is associated with decreased avoidance and negative mood symptoms in women with PTSD. | Q44938346 |
| | Clozapine treatment of adolescents with posttraumatic stress disorder and psychotic symptoms | Q44943732 |
| | Adjunctive risperidone treatment in combat veterans with chronic PTSD. | Q45045062 |
| | Posttraumatic stress disorder in vietnam veterans clinical and EEG findings; possible therapeutic effects of carbamazepine | Q45049321 |
| | A preliminary study of risperidone in the treatment of posttraumatic stress disorder related to childhood abuse in women. | Q45218010 |
| | Remission rates in patients with anxiety disorders treated with paroxetine. | Q45218038 |
| | Pharmacotherapy of PTSD in the U.S. Department of Veterans Affairs: diagnostic- and symptom-guided drug selection. | Q45331843 |
| | Divalproex in the treatment of posttraumatic stress disorder: a randomized, double-blind, placebo-controlled trial in a veteran population | Q45332057 |
| | A parallel group placebo controlled study of prazosin for trauma nightmares and sleep disturbance in combat veterans with post-traumatic stress disorder | Q45332570 |
| | Aripiprazole in the management of post-traumatic stress disorder symptoms in returning Global War on Terrorism veterans | Q45332827 |
| | Clinical case series: the use of Prazosin for combat-related recurrent nightmares among Operation Iraqi Freedom combat veterans | Q45333086 |
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | post-traumatic stress disorder | Q202387 |
| | pharmacology | Q128406 |
| | systematic review | Q1504425 |
| P304 | page(s) | 169-80 | |
| P577 | publication date | 2009-03-17 | |
| P1433 | published in | Progress in Neuro-Psychopharmacology & Biological Psychiatry | Q15616665 |
| P1476 | title | Pharmacologic alternatives to antidepressants in posttraumatic stress disorder: a systematic review | |
| P478 | volume | 33 | |